The oncoprotein LMO2 is expressed in a germinal center B-cell-associated pattern and predicts survival in patients with diffuse large B-cell lymphoma.

被引：0
|
作者：
Natkunam, Yasodha
Hsi, Eric D.
Hans, Christine
Zhao, Shuchun
Taidi, Behnaz
Chen, Jun
Mason, David Y.
Marafioti, Teresa
Jones, Margaret
Pohlman, Brad
Hammer, Anne S.
Hamilton-Dutoit, Stephen
Avigdor, Abraham
Schiby, Ginette
Nagler, Arnon
Byrne, Gerald E., Jr.
Levy, Ronald
Lossos, Izidor S.
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Univ Nebraska Med Ctr, Omaha, NE USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33152 USA
[5] John Radcliffe Hosp, Oxford OX3 9DU, England
[6] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[7] Chaim Sheba Med Ctr, Tel Aviv, Israel
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页码：243A / 243A
页数：1
相关论文
共 50 条
  • [31] Carcinoma erysipelatoides associated with diffuse large B-cell lymphoma.
    Khan, B. Q.
    Gandhi, M.
    Edmonds, H.
    Ahmad, K.
    Rasberry, R. D.
    Corbett, C. E.
    Jakkola, A. F.
    Carbone, L. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S313 - S313
  • [32] LMO2 Negativity Identifies Cases Carrying MYC Translocations in Diffuse Large B-Cell Lymphoma
    Colomo, Luis
    Valera, Alexandra
    Climent, Fina
    Martinez, Daniel
    Gonzalez, Blanca
    Mate, Jose Luis
    Forcada, Pilar
    Mozos, Anna
    Campo, Elias
    LABORATORY INVESTIGATION, 2015, 95 : 340A - 340A
  • [33] LMO2 Negativity Identifies Cases Carrying MYC Translocations in Diffuse Large B-Cell Lymphoma
    Colomo, Luis
    Valera, Alexandra
    Climent, Fina
    Martinez, Daniel
    Gonzalez, Blanca
    Mate, Jose Luis
    Forcada, Pilar
    Mozos, Anna
    Campo, Elias
    MODERN PATHOLOGY, 2015, 28 : 340A - 340A
  • [34] Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS
    Papaleo, Natalia
    Molina-Alvarez, Andrea
    Onieva, Ricard
    Fuertes, Diana
    Sanchez-Gonzalez, Blanca
    Riera, Xenia
    Lopez-Segura, David
    Lome-Maldonado, Carmen
    Ara-Mancebo, Xavier
    Yelamos, Jose
    Salido, Marta
    Vazquez, Ivonne
    Calvo, Xavier
    Colomo, Luis
    CANCERS, 2024, 16 (13)
  • [35] YY1 expression predicts survival in follicular and diffuse large B-cell lymphoma.
    Sakhinia, Ebrahim
    Glennie, Caroline
    Hoyland, Judith A.
    Menasce, Lia
    Radford, John A.
    Byers, Richard J.
    Ebert, Benjamin L.
    BLOOD, 2006, 108 (11) : 576A - 576A
  • [36] Survival outcomes in primary orbital diffuse large B-cell lymphoma.
    Baidoun, Firas
    Hoppe, Bradford S.
    Tun, Han W.
    Moustafa, Muhamad Alhaj
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] LncRNA OR2A1-AS1 index predicts survival in germinal center-like diffuse large B-cell lymphoma
    Ye, Shuting
    Ying, Weiwei
    Lin, Yi
    Hou, Zhengjun
    Su, Meiyun
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (10)
  • [38] Identification of LMO2 Transcriptome and Interactome in Diffuse Large B-Cell Lymphoma by Integrated Experimental and Computational Approach
    Cubedo, Elena
    Gentles, Andrew J.
    Huang, Chuanxin
    Natkunam, Yasodha
    Bhatt, Shruti
    Jiang, Xiaoyu
    Lu, Xiaoqing
    Romero-Camarero, Isabel
    Plevritis, Sylvia K.
    Martinez-Climent, Jose A.
    Sanchez-Garcia, Isidro
    Melnick, Ari
    Lossos, Izidore S.
    BLOOD, 2011, 118 (21) : 201 - 202
  • [39] Immunohistochemical markers in the prognostic model for survival of patients with diffuse large B-cell lymphoma.
    Kobilov, Odiljon
    Kamishov, Sergey
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Fostamatinib for the treatment of diffuse large B-cell lymphoma.
    Arkenau, Hendrik-Tobias
    Patrikidou, Anna
    Flinn, Ian
    Hylton, Jonas C.
    Tong, Sandra
    Ardeshna, Kirit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345